Enjoy complimentary customisation on priority with our Enterprise License!
The automated analyzers market share is expected to increase by USD 1.96 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.53%. This market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. The market report also offers information on several market vendors, including Agilent Technologies Inc., Aurora Biomed Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Drucker Diagnostics LLC, Eppendorf AG, F. Hoffmann La Roche Ltd., Hitachi High Tech Corp., Honeywell International Inc., Hudson Robotics Inc., KPM Analytics, Medsource Ozone Biomedicals Pvt. Ltd., PerkinElmer Inc., Shimadzu Corp., Siemens Healthineers AG, Synchron Lab Automation, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Tosoh Corp. among others. Furthermore, this report extensively covers market segmentation by type (biochemistry analyzers, immuno-based analyzers, and haematology analyzers) and geography (North America, Europe, Asia, and Rest of World (ROW)).
Download the Free Report Sample to Unlock the Market Size for the Forecast Period and Other Important Statistics
The rising prevalence of infectious diseases is notably driving the market growth, although factors such as the shortage of skilled professionals may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the automated analyzers industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Automated Analyzers Market Driver
The rising prevalence of infectious diseases is one of the key drivers supporting market growth. According to the WHO, infectious diseases are the world's leading cause of death, accounting for more than 13 million deaths per year, with one in every two deaths occurring in underdeveloped nations such as Niger, Central African Republic, and Chad. Several infectious diseases, including pneumonia, tuberculosis, malaria, and HIV, account for about 90% of mortality. Infectious disorders are spreading fast in developing countries such as Colombia, China, India, and Iran. Moreover, the growing usage of immunoassay analyzers to diagnose infectious diseases is boosting the growth of the market. Thus, the market is expected to grow at a significant rate during the forecast period.
Key Automated Analyzers Market Trend
Rising clinical diagnostic of immunoassay analyzers for various applications is one of the key market trends that is contributing to the market growth. Immunoassay analyzers are widely used in various significant areas such as pharmaceutical analysis, which includes drug discovery, diagnosis, and others. The analysis involves measuring low concentrations of low molecular weight drugs, metabolites, and biomarkers that indicate disease diagnosis. The significant immunoassay methods in pharmaceutical analysis are inclined to inherent specificity, high throughput, and high sensitivity for the analysis of an extensive range of analytes in biological samples. Thus, the rising adoption of automated immunoassay analyzers for applications such as drug discovery, cardiology, and infectious disease is driving the growth of the market.
Key Automated Analyzers Market Challenge
The shortage of skilled professionals is one of the factors hindering market growth. Automated analyzers are often large and complex and require sophisticated analysis software for various measurement procedures. This means that the operation of these instruments and the analysis of samples require the user to have considerable training. Therefore, companies must invest heavily in providing training to their employees on how to use these instruments effectively. The limited number of such trained professionals is posing challenges to the growth of the market and will continue to do so during the forecast period. Thus, the shortage of skilled labour and the growing sophistication of automated analyzers will prove to be a challenge to the growth of the market during the forecast period.
This market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global automated analyzers market as a part of the global healthcare equipment market.. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the market encompasses successful business strategies deployed by the key vendors. The market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
44% of the market's growth will originate from North America during the forecast period. The US is the key market for automated analyzers in North America. Market growth in this region will be faster than the growth of the market in ROW.
The significant investments in healthcare research and testing will facilitate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the outbreak of COVID-19 positively impacted the market in North America, owing to the increasing need for blood testing for patients with COVID-19 complications. The growth is expected to be the same during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The market share growth by the biochemistry analyzers segment will be significant during the forecast period. Biochemistry analyzers are instruments that are used to examine biological samples such as urine, blood, CSF, and other bodily fluids. It is based on the photochemical concept of Beer-Lambert Law. For testing the qualities of the sample, these devices are equipped with optical and electrochemical technologies. The majority of these analyzers use spectrometric, fluoroscopic, colourimetric, and absorption detection techniques to perform the measurements. Thus, such factors are expected to drive segment growth during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the market size and actionable market insights on post COVID-19 impact on each segment.
Automated Analyzers Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.53% |
Market growth 2022-2026 |
$ 1.96 billion |
Market structure |
Fragmented |
YoY growth (%) |
6.01 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 44% |
Key consumer countries |
US, UK, Germany, France, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Agilent Technologies Inc., Aurora Biomed Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Drucker Diagnostics LLC, Eppendorf AG, F. Hoffmann La Roche Ltd., Hitachi High Tech Corp., Honeywell International Inc., Hudson Robotics Inc., KPM Analytics, Medsource Ozone Biomedicals Pvt. Ltd., PerkinElmer Inc., Shimadzu Corp., Siemens Healthineers AG, Synchron Lab Automation, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Tosoh Corp. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.